Surgical Treatment of Refractory Chest Tumors Assisted by Cardiopulmonary Bypass
Background and objective A retrospective review of the surgical treatment of refractory chest tumors involving the heart or large vessels with cardiopulmonary bypass (CPB). Methods To summarize 11 cases of chest tumor patients who had undergone cardiopulmonary bypass surgery from January 2008 to May...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2018-04-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.04.17 |
| _version_ | 1818535446262579200 |
|---|---|
| author | Rongying ZHU Shanzhou DUAN Wentao YANG Li SHI Fuquan ZHANG Yongbing CHEN |
| author_facet | Rongying ZHU Shanzhou DUAN Wentao YANG Li SHI Fuquan ZHANG Yongbing CHEN |
| author_sort | Rongying ZHU |
| collection | DOAJ |
| description | Background and objective A retrospective review of the surgical treatment of refractory chest tumors involving the heart or large vessels with cardiopulmonary bypass (CPB). Methods To summarize 11 cases of chest tumor patients who had undergone cardiopulmonary bypass surgery from January 2008 to May 2017 in our hospital, and analyze the general condition, clinical characteristics, treatment methods, postoperative hospitalization time, complications and follow-up results of all patients. Results All 11 patients were operated with cardiopulmonary bypass. Total resection of tumors in 8 cases and most of the excision in 3 cases. 1 case of left atrial metastatic leiomyosarcoma were excised in the left atrium, and then the right lung resection was performed. 1 case of left lung central lung cancer resection through the median sternum incision. 2 cases underwent pulmonary artery repair at the same time, 3 cases underwent partial pericardiectomy and 3 cases underwent pulmonary wedge resection at the same time. All the patients were effectively relieved after the operation. No death rate in hospital and 30 days after operation. 3 cases of postoperative pulmonary infection were recovered after the treatment of antibiotics. 1 case of lymphoma relapsed 6 months after surgery and died one year later. 1 case of pericardial fibrosarcoma had local recurrence and extensive metastasis at 13 months after operation, and died after 15 months. 1 case of pulmonary leiomyosarcoma were found to have local recurrence 15 months after the operation and were relieved after chemotherapy. The remaining 8 patients survived, and no obvious recurrence and distant metastasis were found in the computed tomography (CT) examination. Conclusion The CPB assisted surgical treatment can be performed for patient of refractory chest tumors involving the heart or large vessels. It can improve the surgical resection rate of refractory chest tumors, effectively alleviate the effects on respiratory and circulatory functions, and significantly prolong the survival period of these patients. |
| first_indexed | 2024-12-11T18:24:58Z |
| format | Article |
| id | doaj.art-4ff46dc136854594904c0563042d4848 |
| institution | Directory Open Access Journal |
| issn | 1009-3419 1999-6187 |
| language | zho |
| last_indexed | 2024-12-11T18:24:58Z |
| publishDate | 2018-04-01 |
| publisher | Chinese Anti-Cancer Association; Chinese Antituberculosis Association |
| record_format | Article |
| series | Chinese Journal of Lung Cancer |
| spelling | doaj.art-4ff46dc136854594904c0563042d48482022-12-22T00:55:07ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872018-04-0121431331710.3779/j.issn.1009-3419.2018.04.17Surgical Treatment of Refractory Chest Tumors Assisted
by Cardiopulmonary BypassRongying ZHU0Shanzhou DUAN1Wentao YANG2Li SHI3Fuquan ZHANG4Yongbing CHEN5Department of Cardiothoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaBackground and objective A retrospective review of the surgical treatment of refractory chest tumors involving the heart or large vessels with cardiopulmonary bypass (CPB). Methods To summarize 11 cases of chest tumor patients who had undergone cardiopulmonary bypass surgery from January 2008 to May 2017 in our hospital, and analyze the general condition, clinical characteristics, treatment methods, postoperative hospitalization time, complications and follow-up results of all patients. Results All 11 patients were operated with cardiopulmonary bypass. Total resection of tumors in 8 cases and most of the excision in 3 cases. 1 case of left atrial metastatic leiomyosarcoma were excised in the left atrium, and then the right lung resection was performed. 1 case of left lung central lung cancer resection through the median sternum incision. 2 cases underwent pulmonary artery repair at the same time, 3 cases underwent partial pericardiectomy and 3 cases underwent pulmonary wedge resection at the same time. All the patients were effectively relieved after the operation. No death rate in hospital and 30 days after operation. 3 cases of postoperative pulmonary infection were recovered after the treatment of antibiotics. 1 case of lymphoma relapsed 6 months after surgery and died one year later. 1 case of pericardial fibrosarcoma had local recurrence and extensive metastasis at 13 months after operation, and died after 15 months. 1 case of pulmonary leiomyosarcoma were found to have local recurrence 15 months after the operation and were relieved after chemotherapy. The remaining 8 patients survived, and no obvious recurrence and distant metastasis were found in the computed tomography (CT) examination. Conclusion The CPB assisted surgical treatment can be performed for patient of refractory chest tumors involving the heart or large vessels. It can improve the surgical resection rate of refractory chest tumors, effectively alleviate the effects on respiratory and circulatory functions, and significantly prolong the survival period of these patients.http://dx.doi.org/10.3779/j.issn.1009-3419.2018.04.17Thoracic tumorCardiopulmonary bypassSurgical treatment |
| spellingShingle | Rongying ZHU Shanzhou DUAN Wentao YANG Li SHI Fuquan ZHANG Yongbing CHEN Surgical Treatment of Refractory Chest Tumors Assisted by Cardiopulmonary Bypass Chinese Journal of Lung Cancer Thoracic tumor Cardiopulmonary bypass Surgical treatment |
| title | Surgical Treatment of Refractory Chest Tumors Assisted
by Cardiopulmonary Bypass |
| title_full | Surgical Treatment of Refractory Chest Tumors Assisted
by Cardiopulmonary Bypass |
| title_fullStr | Surgical Treatment of Refractory Chest Tumors Assisted
by Cardiopulmonary Bypass |
| title_full_unstemmed | Surgical Treatment of Refractory Chest Tumors Assisted
by Cardiopulmonary Bypass |
| title_short | Surgical Treatment of Refractory Chest Tumors Assisted
by Cardiopulmonary Bypass |
| title_sort | surgical treatment of refractory chest tumors assisted
by cardiopulmonary bypass |
| topic | Thoracic tumor Cardiopulmonary bypass Surgical treatment |
| url | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.04.17 |
| work_keys_str_mv | AT rongyingzhu surgicaltreatmentofrefractorychesttumorsassistedbycardiopulmonarybypass AT shanzhouduan surgicaltreatmentofrefractorychesttumorsassistedbycardiopulmonarybypass AT wentaoyang surgicaltreatmentofrefractorychesttumorsassistedbycardiopulmonarybypass AT lishi surgicaltreatmentofrefractorychesttumorsassistedbycardiopulmonarybypass AT fuquanzhang surgicaltreatmentofrefractorychesttumorsassistedbycardiopulmonarybypass AT yongbingchen surgicaltreatmentofrefractorychesttumorsassistedbycardiopulmonarybypass |